Tianjin Chase Sun Pharmaceutical Co.,Ltd Statistics

Total Valuation

Tianjin Chase Sun Pharmaceutical Co.,Ltd has a market cap or net worth of CNY 12.17 billion. The enterprise value is 12.13 billion.

Market Cap	12.17B
Enterprise Value	12.13B

Important Dates

The last earnings date was Friday, October 25, 2024.

Earnings Date	Oct 25, 2024
Ex-Dividend Date	May 23, 2024

Share Statistics

Tianjin Chase Sun Pharmaceutical Co.,Ltd has 3.00 billion shares outstanding. The number of shares has decreased by -5.83% in one year.

Current Share Class	n/a
Shares Outstanding	3.00B
Shares Change (YoY)	-5.83%
Shares Change (QoQ)	-17.69%
Owned by Insiders (%)	11.95%
Owned by Institutions (%)	9.58%
Float	1.82B

Valuation Ratios

The trailing PE ratio is 69.33 and the forward PE ratio is 22.50.

PE Ratio	69.33
Forward PE	22.50
PS Ratio	2.04
PB Ratio	1.38
P/TBV Ratio	n/a
P/FCF Ratio	16.50
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 22.79, with an EV/FCF ratio of 16.45.

EV / Earnings	73.16
EV / Sales	2.16
EV / EBITDA	22.79
EV / EBIT	70.56
EV / FCF	16.45

Financial Position

The company has a current ratio of 3.76, with a Debt / Equity ratio of 0.10.

Current Ratio	3.76
Quick Ratio	2.46
Debt / Equity	0.10
Debt / EBITDA	1.71
Debt / FCF	1.23
Interest Coverage	3.10

Financial Efficiency

Return on equity (ROE) is 2.04% and return on invested capital (ROIC) is 1.05%.

Return on Equity (ROE)	2.04%
Return on Assets (ROA)	0.90%
Return on Capital (ROIC)	1.05%
Revenue Per Employee	952,198
Profits Per Employee	28,055
Employee Count	5,910
Asset Turnover	0.47
Inventory Turnover	1.36

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -7.95% in the last 52 weeks. The beta is -0.07, so Tianjin Chase Sun Pharmaceutical Co.,Ltd's price volatility has been lower than the market average.

Beta (5Y)	-0.07
52-Week Price Change	-7.95%
50-Day Moving Average	3.74
200-Day Moving Average	3.63
Relative Strength Index (RSI)	53.93
Average Volume (20 Days)	105,327,159

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Tianjin Chase Sun Pharmaceutical Co.,Ltd had revenue of CNY 5.63 billion and earned 165.81 million in profits. Earnings per share was 0.06.

Revenue	5.63B
Gross Profit	2.88B
Operating Income	171.91M
Pretax Income	214.71M
Net Income	165.81M
EBITDA	478.23M
EBIT	171.91M
Earnings Per Share (EPS)	0.06

Full Income Statement

Balance Sheet

The company has 1.12 billion in cash and 909.16 million in debt, giving a net cash position of 210.19 million or 0.07 per share.

Cash & Cash Equivalents	1.12B
Total Debt	909.16M
Net Cash	210.19M
Net Cash Per Share	0.07
Equity (Book Value)	8.96B
Book Value Per Share	2.92
Working Capital	4.61B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 1.04 billion and capital expenditures -305.12 million, giving a free cash flow of 737.51 million.

Operating Cash Flow	1.04B
Capital Expenditures	-305.12M
Free Cash Flow	737.51M
FCF Per Share	0.25

Full Cash Flow Statement

Margins

Gross margin is 51.12%, with operating and profit margins of 3.05% and 2.95%.

Gross Margin	51.12%
Operating Margin	3.05%
Pretax Margin	3.82%
Profit Margin	2.95%
EBITDA Margin	8.50%
EBIT Margin	3.05%
FCF Margin	13.11%

Dividends & Yields

This stock pays an annual dividend of 0.03, which amounts to a dividend yield of 0.72%.

Dividend Per Share	0.03
Dividend Yield	0.72%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	83.56%
Buyback Yield	5.83%
Shareholder Yield	6.55%
Earnings Yield	1.44%
FCF Yield	6.06%

Dividend Details

Stock Splits

The last stock split was on October 26, 2016. It was a forward split with a ratio of 3.

Last Split Date	Oct 26, 2016
Split Type	Forward
Split Ratio	3

Scores

Tianjin Chase Sun Pharmaceutical Co.,Ltd has an Altman Z-Score of 4.51.

Altman Z-Score	4.51
Piotroski F-Score	n/a